The US Tumor Embolization Market landscape, Procedure Volumes, Brand Perception and Future Outlook report is the first ever syndicated report that covers the standard of care, procedure volumes and physician perception of the medical devices used in tumor embolization procedures. The report is based on responses from performing physicians in Interventional Radiology departments from university hospitals, community teaching/non-teaching hospitals and private practice.
The number of tumor embolization procedures were estimated to be around 87,000 in 2019.The 5-year forecast of procedure volumes till 2022 along with the headwinds and tailwinds are covered comprehensively in the report. The report has details on tumor embolization techniques used to treat different cancer types. The report captures embolization techniques such as nCBA, radio embolization (Y90), Bland embolization/transarterial chemoembolization (TACE), DEB-TACE, coil/micro coil embolization.
The report also highlights the interventional oncology care continuum and offers valuable insights on patient referrals pathway, hospital structure and utilization, physician treatment selection criteria, current and upcoming policies for diagnosis and treatment, and payer coverage.
The report provides physician’s brand perception and ranks medical device companies based on 15 KPI’s such as technology, clinical evidence, patient outcome, etc. Moreover, diligent examination of physician’s brand usage and brand satisfaction levels, and the factors such as ease of use of device, cost effectiveness among others effecting brand usage have been covered
The report provides information on the future trends such as growing awareness among interventional radiologists, high procedural success rates and increase in usage with other systemic therapies. Expanded indications such as prostate cancer, potential usage in gastroenterology, cardiology and gynecology and combination therapy with ablation are potential game changers to watch out for in the growing tumor embolization market.
This report will help interventional oncology devices companies understand the tumor embolization devices market landscape in the US, the current and future procedure volumes, the brand perception, device usage trends, and challenges faced by interventionalists in the US. The report is a great resource to plan your market strategy to capitalize on upcoming trends and potential disruptors in the tumor embolization market.
The deliverable includes a 100+ slide MS PowerPoint report and an MS Excel-based 5-Year market forecast model.
Contact us for further details regarding the exclusive data and insights in the report or for an exploratory analyst walk through of the report.